Click for best price
Toxoid Vaccines Market Size, Share 2022
Market Analysis and Insights: Global Toxoid Vaccines Market
The global Toxoid Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Toxoid Vaccines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Toxoid Vaccines market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Toxoid Vaccines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Toxoid Vaccines market.
Global Toxoid Vaccines Scope and Market Size
Toxoid Vaccines market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Toxoid Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Monovalent Tetanus Toxoid (TT)
Diphtheria
Tetanus
Pertussis (DTaP)
Diphtheria and Tetanus (DT)
Segment by Application
Hospitals And Clinics
Government Organizations
Research
Others
By Company
GlaxoSmithKline
Merck
Pfizer
Sanofi Pasteur
AstraZeneca
Bharat Biotech
Shenzhen Kangtai Biological Products
Bausch Health
Emergent Biosolutions
Astellas Pharma
Panacea Biotec
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Toxoid Vaccines product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Toxoid Vaccines, with price, sales, revenue, and global market share of Toxoid Vaccines from 2019 to 2022.
Chapter 3, the Toxoid Vaccines competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Toxoid Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Toxoid Vaccines market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Toxoid Vaccines.
Chapter 13, 14, and 15, to describe Toxoid Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Toxoid Vaccines Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global Toxoid Vaccines Market Insights, Forecast to 2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
110 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Toxoid Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Toxoid Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Monovalent Tetanus Toxoid (TT)
1.2.3 Diphtheria
1.2.4 Tetanus
1.2.5 Pertussis (DTaP)
1.2.6 Diphtheria and Tetanus (DT)
1.3 Market by Application
1.3.1 Global Toxoid Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals And Clinics
1.3.3 Government Organizations
1.3.4 Research
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Toxoid Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global Toxoid Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global Toxoid Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Toxoid Vaccines Sales by Region
2.4.1 Global Toxoid Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales Toxoid Vaccines by Region (2023-2028)
2.5 Global Toxoid Vaccines Revenue by Region
2.5.1 Global Toxoid Vaccines Revenue by Region (2017-2022)
2.5.2 Global Toxoid Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Toxoid Vaccines Sales by Manufacturers
3.1.1 Global Top Toxoid Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global Toxoid Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Toxoid Vaccines in 2021
3.2 Global Toxoid Vaccines Revenue by Manufacturers
3.2.1 Global Toxoid Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global Toxoid Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Toxoid Vaccines Revenue in 2021
3.3 Global Toxoid Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Toxoid Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Toxoid Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Toxoid Vaccines Sales by Type
4.1.1 Global Toxoid Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global Toxoid Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global Toxoid Vaccines Sales Market Share by Type (2017-2028)
4.2 Global Toxoid Vaccines Revenue by Type
4.2.1 Global Toxoid Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global Toxoid Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global Toxoid Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global Toxoid Vaccines Price by Type
4.3.1 Global Toxoid Vaccines Price by Type (2017-2022)
4.3.2 Global Toxoid Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Toxoid Vaccines Sales by Application
5.1.1 Global Toxoid Vaccines Historical Sales by Application (2017-2022)
5.1.2 Global Toxoid Vaccines Forecasted Sales by Application (2023-2028)
5.1.3 Global Toxoid Vaccines Sales Market Share by Application (2017-2028)
5.2 Global Toxoid Vaccines Revenue by Application
5.2.1 Global Toxoid Vaccines Historical Revenue by Application (2017-2022)
5.2.2 Global Toxoid Vaccines Forecasted Revenue by Application (2023-2028)
5.2.3 Global Toxoid Vaccines Revenue Market Share by Application (2017-2028)
5.3 Global Toxoid Vaccines Price by Application
5.3.1 Global Toxoid Vaccines Price by Application (2017-2022)
5.3.2 Global Toxoid Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Toxoid Vaccines Market Size by Type
6.1.1 North America Toxoid Vaccines Sales by Type (2017-2028)
6.1.2 North America Toxoid Vaccines Revenue by Type (2017-2028)
6.2 North America Toxoid Vaccines Market Size by Application
6.2.1 North America Toxoid Vaccines Sales by Application (2017-2028)
6.2.2 North America Toxoid Vaccines Revenue by Application (2017-2028)
6.3 North America Toxoid Vaccines Market Size by Country
6.3.1 North America Toxoid Vaccines Sales by Country (2017-2028)
6.3.2 North America Toxoid Vaccines Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Toxoid Vaccines Market Size by Type
7.1.1 Europe Toxoid Vaccines Sales by Type (2017-2028)
7.1.2 Europe Toxoid Vaccines Revenue by Type (2017-2028)
7.2 Europe Toxoid Vaccines Market Size by Application
7.2.1 Europe Toxoid Vaccines Sales by Application (2017-2028)
7.2.2 Europe Toxoid Vaccines Revenue by Application (2017-2028)
7.3 Europe Toxoid Vaccines Market Size by Country
7.3.1 Europe Toxoid Vaccines Sales by Country (2017-2028)
7.3.2 Europe Toxoid Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Toxoid Vaccines Market Size by Type
8.1.1 Asia Pacific Toxoid Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific Toxoid Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific Toxoid Vaccines Market Size by Application
8.2.1 Asia Pacific Toxoid Vaccines Sales by Application (2017-2028)
8.2.2 Asia Pacific Toxoid Vaccines Revenue by Application (2017-2028)
8.3 Asia Pacific Toxoid Vaccines Market Size by Region
8.3.1 Asia Pacific Toxoid Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific Toxoid Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Toxoid Vaccines Market Size by Type
9.1.1 Latin America Toxoid Vaccines Sales by Type (2017-2028)
9.1.2 Latin America Toxoid Vaccines Revenue by Type (2017-2028)
9.2 Latin America Toxoid Vaccines Market Size by Application
9.2.1 Latin America Toxoid Vaccines Sales by Application (2017-2028)
9.2.2 Latin America Toxoid Vaccines Revenue by Application (2017-2028)
9.3 Latin America Toxoid Vaccines Market Size by Country
9.3.1 Latin America Toxoid Vaccines Sales by Country (2017-2028)
9.3.2 Latin America Toxoid Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Toxoid Vaccines Market Size by Type
10.1.1 Middle East and Africa Toxoid Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa Toxoid Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa Toxoid Vaccines Market Size by Application
10.2.1 Middle East and Africa Toxoid Vaccines Sales by Application (2017-2028)
10.2.2 Middle East and Africa Toxoid Vaccines Revenue by Application (2017-2028)
10.3 Middle East and Africa Toxoid Vaccines Market Size by Country
10.3.1 Middle East and Africa Toxoid Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Toxoid Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Overview
11.1.3 GlaxoSmithKline Toxoid Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 GlaxoSmithKline Toxoid Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GlaxoSmithKline Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Overview
11.2.3 Merck Toxoid Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Merck Toxoid Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Recent Developments
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Overview
11.3.3 Pfizer Toxoid Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Pfizer Toxoid Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pfizer Recent Developments
11.4 Sanofi Pasteur
11.4.1 Sanofi Pasteur Corporation Information
11.4.2 Sanofi Pasteur Overview
11.4.3 Sanofi Pasteur Toxoid Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sanofi Pasteur Toxoid Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sanofi Pasteur Recent Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Corporation Information
11.5.2 AstraZeneca Overview
11.5.3 AstraZeneca Toxoid Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 AstraZeneca Toxoid Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 AstraZeneca Recent Developments
11.6 Bharat Biotech
11.6.1 Bharat Biotech Corporation Information
11.6.2 Bharat Biotech Overview
11.6.3 Bharat Biotech Toxoid Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Bharat Biotech Toxoid Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bharat Biotech Recent Developments
11.7 Shenzhen Kangtai Biological Products
11.7.1 Shenzhen Kangtai Biological Products Corporation Information
11.7.2 Shenzhen Kangtai Biological Products Overview
11.7.3 Shenzhen Kangtai Biological Products Toxoid Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Shenzhen Kangtai Biological Products Toxoid Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Shenzhen Kangtai Biological Products Recent Developments
11.8 Bausch Health
11.8.1 Bausch Health Corporation Information
11.8.2 Bausch Health Overview
11.8.3 Bausch Health Toxoid Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Bausch Health Toxoid Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bausch Health Recent Developments
11.9 Emergent Biosolutions
11.9.1 Emergent Biosolutions Corporation Information
11.9.2 Emergent Biosolutions Overview
11.9.3 Emergent Biosolutions Toxoid Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Emergent Biosolutions Toxoid Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Emergent Biosolutions Recent Developments
11.10 Astellas Pharma
11.10.1 Astellas Pharma Corporation Information
11.10.2 Astellas Pharma Overview
11.10.3 Astellas Pharma Toxoid Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Astellas Pharma Toxoid Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Astellas Pharma Recent Developments
11.11 Panacea Biotec
11.11.1 Panacea Biotec Corporation Information
11.11.2 Panacea Biotec Overview
11.11.3 Panacea Biotec Toxoid Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Panacea Biotec Toxoid Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Panacea Biotec Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Toxoid Vaccines Industry Chain Analysis
12.2 Toxoid Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Toxoid Vaccines Production Mode & Process
12.4 Toxoid Vaccines Sales and Marketing
12.4.1 Toxoid Vaccines Sales Channels
12.4.2 Toxoid Vaccines Distributors
12.5 Toxoid Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Toxoid Vaccines Industry Trends
13.2 Toxoid Vaccines Market Drivers
13.3 Toxoid Vaccines Market Challenges
13.4 Toxoid Vaccines Market Restraints
14 Key Findings in The Global Toxoid Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Global Toxoid Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Monovalent Tetanus Toxoid (TT)
Table 3. Major Manufacturers of Diphtheria
Table 4. Major Manufacturers of Tetanus
Table 5. Major Manufacturers of Pertussis (DTaP)
Table 6. Major Manufacturers of Diphtheria and Tetanus (DT)
Table 7. Global Toxoid Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Toxoid Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Toxoid Vaccines Sales by Region (2017-2022) & (K Units)
Table 10. Global Toxoid Vaccines Sales Market Share by Region (2017-2022)
Table 11. Global Toxoid Vaccines Sales by Region (2023-2028) & (K Units)
Table 12. Global Toxoid Vaccines Sales Market Share by Region (2023-2028)
Table 13. Global Toxoid Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Toxoid Vaccines Revenue Market Share by Region (2017-2022)
Table 15. Global Toxoid Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Toxoid Vaccines Revenue Market Share by Region (2023-2028)
Table 17. Global Toxoid Vaccines Sales by Manufacturers (2017-2022) & (K Units)
Table 18. Global Toxoid Vaccines Sales Share by Manufacturers (2017-2022)
Table 19. Global Toxoid Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Toxoid Vaccines Revenue Share by Manufacturers (2017-2022)
Table 21. Toxoid Vaccines Price by Manufacturers (2017-2022) &(USD/Unit)
Table 22. Global Toxoid Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Toxoid Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Toxoid Vaccines as of 2021)
Table 24. Toxoid Vaccines Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Toxoid Vaccines Product Offered
Table 26. Date of Manufacturers Enter into Toxoid Vaccines Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Toxoid Vaccines Sales by Type (2017-2022) & (K Units)
Table 29. Global Toxoid Vaccines Sales by Type (2023-2028) & (K Units)
Table 30. Global Toxoid Vaccines Sales Share by Type (2017-2022)
Table 31. Global Toxoid Vaccines Sales Share by Type (2023-2028)
Table 32. Global Toxoid Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Toxoid Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Toxoid Vaccines Revenue Share by Type (2017-2022)
Table 35. Global Toxoid Vaccines Revenue Share by Type (2023-2028)
Table 36. Toxoid Vaccines Price by Type (2017-2022) & (USD/Unit)
Table 37. Global Toxoid Vaccines Price Forecast by Type (2023-2028) & (USD/Unit)
Table 38. Global Toxoid Vaccines Sales by Application (2017-2022) & (K Units)
Table 39. Global Toxoid Vaccines Sales by Application (2023-2028) & (K Units)
Table 40. Global Toxoid Vaccines Sales Share by Application (2017-2022)
Table 41. Global Toxoid Vaccines Sales Share by Application (2023-2028)
Table 42. Global Toxoid Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Toxoid Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Toxoid Vaccines Revenue Share by Application (2017-2022)
Table 45. Global Toxoid Vaccines Revenue Share by Application (2023-2028)
Table 46. Toxoid Vaccines Price by Application (2017-2022) & (USD/Unit)
Table 47. Global Toxoid Vaccines Price Forecast by Application (2023-2028) & (USD/Unit)
Table 48. North America Toxoid Vaccines Sales by Type (2017-2022) & (K Units)
Table 49. North America Toxoid Vaccines Sales by Type (2023-2028) & (K Units)
Table 50. North America Toxoid Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Toxoid Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Toxoid Vaccines Sales by Application (2017-2022) & (K Units)
Table 53. North America Toxoid Vaccines Sales by Application (2023-2028) & (K Units)
Table 54. North America Toxoid Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Toxoid Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Toxoid Vaccines Sales by Country (2017-2022) & (K Units)
Table 57. North America Toxoid Vaccines Sales by Country (2023-2028) & (K Units)
Table 58. North America Toxoid Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Toxoid Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Toxoid Vaccines Sales by Type (2017-2022) & (K Units)
Table 61. Europe Toxoid Vaccines Sales by Type (2023-2028) & (K Units)
Table 62. Europe Toxoid Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Toxoid Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Toxoid Vaccines Sales by Application (2017-2022) & (K Units)
Table 65. Europe Toxoid Vaccines Sales by Application (2023-2028) & (K Units)
Table 66. Europe Toxoid Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Toxoid Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Toxoid Vaccines Sales by Country (2017-2022) & (K Units)
Table 69. Europe Toxoid Vaccines Sales by Country (2023-2028) & (K Units)
Table 70. Europe Toxoid Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Toxoid Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Toxoid Vaccines Sales by Type (2017-2022) & (K Units)
Table 73. Asia Pacific Toxoid Vaccines Sales by Type (2023-2028) & (K Units)
Table 74. Asia Pacific Toxoid Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Toxoid Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Toxoid Vaccines Sales by Application (2017-2022) & (K Units)
Table 77. Asia Pacific Toxoid Vaccines Sales by Application (2023-2028) & (K Units)
Table 78. Asia Pacific Toxoid Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Toxoid Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Toxoid Vaccines Sales by Region (2017-2022) & (K Units)
Table 81. Asia Pacific Toxoid Vaccines Sales by Region (2023-2028) & (K Units)
Table 82. Asia Pacific Toxoid Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Toxoid Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Toxoid Vaccines Sales by Type (2017-2022) & (K Units)
Table 85. Latin America Toxoid Vaccines Sales by Type (2023-2028) & (K Units)
Table 86. Latin America Toxoid Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Toxoid Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Toxoid Vaccines Sales by Application (2017-2022) & (K Units)
Table 89. Latin America Toxoid Vaccines Sales by Application (2023-2028) & (K Units)
Table 90. Latin America Toxoid Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Toxoid Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Toxoid Vaccines Sales by Country (2017-2022) & (K Units)
Table 93. Latin America Toxoid Vaccines Sales by Country (2023-2028) & (K Units)
Table 94. Latin America Toxoid Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Toxoid Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Toxoid Vaccines Sales by Type (2017-2022) & (K Units)
Table 97. Middle East and Africa Toxoid Vaccines Sales by Type (2023-2028) & (K Units)
Table 98. Middle East and Africa Toxoid Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Toxoid Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Toxoid Vaccines Sales by Application (2017-2022) & (K Units)
Table 101. Middle East and Africa Toxoid Vaccines Sales by Application (2023-2028) & (K Units)
Table 102. Middle East and Africa Toxoid Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Toxoid Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Toxoid Vaccines Sales by Country (2017-2022) & (K Units)
Table 105. Middle East and Africa Toxoid Vaccines Sales by Country (2023-2028) & (K Units)
Table 106. Middle East and Africa Toxoid Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Toxoid Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 108. GlaxoSmithKline Corporation Information
Table 109. GlaxoSmithKline Description and Major Businesses
Table 110. GlaxoSmithKline Toxoid Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 111. GlaxoSmithKline Toxoid Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. GlaxoSmithKline Recent Developments
Table 113. Merck Corporation Information
Table 114. Merck Description and Major Businesses
Table 115. Merck Toxoid Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 116. Merck Toxoid Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Merck Recent Developments
Table 118. Pfizer Corporation Information
Table 119. Pfizer Description and Major Businesses
Table 120. Pfizer Toxoid Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 121. Pfizer Toxoid Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Pfizer Recent Developments
Table 123. Sanofi Pasteur Corporation Information
Table 124. Sanofi Pasteur Description and Major Businesses
Table 125. Sanofi Pasteur Toxoid Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 126. Sanofi Pasteur Toxoid Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Sanofi Pasteur Recent Developments
Table 128. AstraZeneca Corporation Information
Table 129. AstraZeneca Description and Major Businesses
Table 130. AstraZeneca Toxoid Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 131. AstraZeneca Toxoid Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. AstraZeneca Recent Developments
Table 133. Bharat Biotech Corporation Information
Table 134. Bharat Biotech Description and Major Businesses
Table 135. Bharat Biotech Toxoid Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 136. Bharat Biotech Toxoid Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Bharat Biotech Recent Developments
Table 138. Shenzhen Kangtai Biological Products Corporation Information
Table 139. Shenzhen Kangtai Biological Products Description and Major Businesses
Table 140. Shenzhen Kangtai Biological Products Toxoid Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 141. Shenzhen Kangtai Biological Products Toxoid Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Shenzhen Kangtai Biological Products Recent Developments
Table 143. Bausch Health Corporation Information
Table 144. Bausch Health Description and Major Businesses
Table 145. Bausch Health Toxoid Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 146. Bausch Health Toxoid Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Bausch Health Recent Developments
Table 148. Emergent Biosolutions Corporation Information
Table 149. Emergent Biosolutions Description and Major Businesses
Table 150. Emergent Biosolutions Toxoid Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 151. Emergent Biosolutions Toxoid Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Emergent Biosolutions Recent Developments
Table 153. Astellas Pharma Corporation Information
Table 154. Astellas Pharma Description and Major Businesses
Table 155. Astellas Pharma Toxoid Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 156. Astellas Pharma Toxoid Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Astellas Pharma Recent Developments
Table 158. Panacea Biotec Corporation Information
Table 159. Panacea Biotec Description and Major Businesses
Table 160. Panacea Biotec Toxoid Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 161. Panacea Biotec Toxoid Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Panacea Biotec Recent Developments
Table 163. Key Raw Materials Lists
Table 164. Raw Materials Key Suppliers Lists
Table 165. Toxoid Vaccines Distributors List
Table 166. Toxoid Vaccines Customers List
Table 167. Toxoid Vaccines Market Trends
Table 168. Toxoid Vaccines Market Drivers
Table 169. Toxoid Vaccines Market Challenges
Table 170. Toxoid Vaccines Market Restraints
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Toxoid Vaccines Product Picture
Figure 3. Global Toxoid Vaccines Market Share by Type in 2021 & 2028
Figure 3. Monovalent Tetanus Toxoid (TT) Product Picture
Figure 4. Diphtheria Product Picture
Figure 5. Tetanus Product Picture
Figure 6. Pertussis (DTaP) Product Picture
Figure 7. Diphtheria and Tetanus (DT) Product Picture
Figure 8. Global Toxoid Vaccines Market Share by Application in 2021 & 2028
Figure 9. Hospitals And Clinics
Figure 10. Government Organizations
Figure 11. Research
Figure 12. Others
Figure 13. Toxoid Vaccines Report Years Considered
Figure 14. Global Toxoid Vaccines Sales 2017-2028 (K Units)
Figure 15. Global Toxoid Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Toxoid Vaccines Revenue 2017-2028 (US$ Million)
Figure 17. Global Toxoid Vaccines Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 18. Global Toxoid Vaccines Sales Market Share by Region (2017-2022)
Figure 19. Global Toxoid Vaccines Sales Market Share by Region (2023-2028)
Figure 20. North America Toxoid Vaccines Sales YoY (2017-2028) & (K Units)
Figure 21. North America Toxoid Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Europe Toxoid Vaccines Sales YoY (2017-2028) & (K Units)
Figure 23. Europe Toxoid Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Asia-Pacific Toxoid Vaccines Sales YoY (2017-2028) & (K Units)
Figure 25. Asia-Pacific Toxoid Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Latin America Toxoid Vaccines Sales YoY (2017-2028) & (K Units)
Figure 27. Latin America Toxoid Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Middle East & Africa Toxoid Vaccines Sales YoY (2017-2028) & (K Units)
Figure 29. Middle East & Africa Toxoid Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 30. The Toxoid Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 31. The Top 5 and 10 Largest Manufacturers of Toxoid Vaccines in the World: Market Share by Toxoid Vaccines Revenue in 2021
Figure 32. Global Toxoid Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 33. Global Toxoid Vaccines Sales Market Share by Type (2017-2028)
Figure 34. Global Toxoid Vaccines Revenue Market Share by Type (2017-2028)
Figure 35. Global Toxoid Vaccines Sales Market Share by Application (2017-2028)
Figure 36. Global Toxoid Vaccines Revenue Market Share by Application (2017-2028)
Figure 37. North America Toxoid Vaccines Sales Market Share by Type (2017-2028)
Figure 38. North America Toxoid Vaccines Revenue Market Share by Type (2017-2028)
Figure 39. North America Toxoid Vaccines Sales Market Share by Application (2017-2028)
Figure 40. North America Toxoid Vaccines Revenue Market Share by Application (2017-2028)
Figure 41. North America Toxoid Vaccines Sales Share by Country (2017-2028)
Figure 42. North America Toxoid Vaccines Revenue Share by Country (2017-2028)
Figure 43. U.S. Toxoid Vaccines Revenue (2017-2028) & (US$ Million)
Figure 44. Canada Toxoid Vaccines Revenue (2017-2028) & (US$ Million)
Figure 45. Europe Toxoid Vaccines Sales Market Share by Type (2017-2028)
Figure 46. Europe Toxoid Vaccines Revenue Market Share by Type (2017-2028)
Figure 47. Europe Toxoid Vaccines Sales Market Share by Application (2017-2028)
Figure 48. Europe Toxoid Vaccines Revenue Market Share by Application (2017-2028)
Figure 49. Europe Toxoid Vaccines Sales Share by Country (2017-2028)
Figure 50. Europe Toxoid Vaccines Revenue Share by Country (2017-2028)
Figure 51. Germany Toxoid Vaccines Revenue (2017-2028) & (US$ Million)
Figure 52. France Toxoid Vaccines Revenue (2017-2028) & (US$ Million)
Figure 53. U.K. Toxoid Vaccines Revenue (2017-2028) & (US$ Million)
Figure 54. Italy Toxoid Vaccines Revenue (2017-2028) & (US$ Million)
Figure 55. Russia Toxoid Vaccines Revenue (2017-2028) & (US$ Million)
Figure 56. Asia Pacific Toxoid Vaccines Sales Market Share by Type (2017-2028)
Figure 57. Asia Pacific Toxoid Vaccines Revenue Market Share by Type (2017-2028)
Figure 58. Asia Pacific Toxoid Vaccines Sales Market Share by Application (2017-2028)
Figure 59. Asia Pacific Toxoid Vaccines Revenue Market Share by Application (2017-2028)
Figure 60. Asia Pacific Toxoid Vaccines Sales Share by Region (2017-2028)
Figure 61. Asia Pacific Toxoid Vaccines Revenue Share by Region (2017-2028)
Figure 62. China Toxoid Vaccines Revenue (2017-2028) & (US$ Million)
Figure 63. Japan Toxoid Vaccines Revenue (2017-2028) & (US$ Million)
Figure 64. South Korea Toxoid Vaccines Revenue (2017-2028) & (US$ Million)
Figure 65. India Toxoid Vaccines Revenue (2017-2028) & (US$ Million)
Figure 66. Australia Toxoid Vaccines Revenue (2017-2028) & (US$ Million)
Figure 67. Taiwan Toxoid Vaccines Revenue (2017-2028) & (US$ Million)
Figure 68. Indonesia Toxoid Vaccines Revenue (2017-2028) & (US$ Million)
Figure 69. Thailand Toxoid Vaccines Revenue (2017-2028) & (US$ Million)
Figure 70. Malaysia Toxoid Vaccines Revenue (2017-2028) & (US$ Million)
Figure 71. Philippines Toxoid Vaccines Revenue (2017-2028) & (US$ Million)
Figure 72. Latin America Toxoid Vaccines Sales Market Share by Type (2017-2028)
Figure 73. Latin America Toxoid Vaccines Revenue Market Share by Type (2017-2028)
Figure 74. Latin America Toxoid Vaccines Sales Market Share by Application (2017-2028)
Figure 75. Latin America Toxoid Vaccines Revenue Market Share by Application (2017-2028)
Figure 76. Latin America Toxoid Vaccines Sales Share by Country (2017-2028)
Figure 77. Latin America Toxoid Vaccines Revenue Share by Country (2017-2028)
Figure 78. Mexico Toxoid Vaccines Revenue (2017-2028) & (US$ Million)
Figure 79. Brazil Toxoid Vaccines Revenue (2017-2028) & (US$ Million)
Figure 80. Argentina Toxoid Vaccines Revenue (2017-2028) & (US$ Million)
Figure 81. Middle East and Africa Toxoid Vaccines Sales Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Toxoid Vaccines Revenue Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Toxoid Vaccines Sales Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Toxoid Vaccines Revenue Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Toxoid Vaccines Sales Share by Country (2017-2028)
Figure 86. Middle East and Africa Toxoid Vaccines Revenue Share by Country (2017-2028)
Figure 87. Turkey Toxoid Vaccines Revenue (2017-2028) & (US$ Million)
Figure 88. Saudi Arabia Toxoid Vaccines Revenue (2017-2028) & (US$ Million)
Figure 89. U.A.E Toxoid Vaccines Revenue (2017-2028) & (US$ Million)
Figure 90. Toxoid Vaccines Value Chain
Figure 91. Toxoid Vaccines Production Process
Figure 92. Channels of Distribution
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed
